Bionano Genomics to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on June 18

Rhea-AI Summary

Bionano Genomics, Inc. (NASDAQ: BNGO) has announced a conference call and live webcast on June 18, 2020, at 4:30 p.m. Eastern Time. The call aims to disclose financial results for the first quarter ended March 31, 2020, and provide a business update. Bionano specializes in structural variation detection in genome analysis through its Saphyr® platform. This call will be significant for investors looking to understand the company's performance and future direction.

Positive

• Announcement of upcoming conference call to discuss Q1 2020 financial results.
• Focus on structural variation detection positions Bionano as a leader in genome analysis.

Negative

• None.

SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr^®, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today announced that it will host a conference call and live webcast on Thursday, June 18, 2020 at 4:30 p.m. Eastern Time to report financial results for its first quarter ended March 31, 2020 and provide a business update.

100%; border-collapse:collapse !important;">

Conference Call & Webcast Details
15%; width:15%; min-width:15%;">Date:	85%; width:85%; min-width:85%;">Thursday, June 18
Time:	4:30 p.m. Eastern Time
Toll Free:	877-407-0784
International:	201-689-8560
Conference ID:	13703823
Webcast:	http://public.viavid.com/index.php?id=139909

To access the call, participants should dial the applicable telephone number above at least 5 minutes prior to the start of the call.  An archived version of the webcast will be available for replay in the Investors section of the Bionano website.

About Bionano Genomics
Bionano is a genome analysis company focused on structural variation detection. The Company’s Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system comprises an instrument, chip consumables, reagents and a suite of data analysis tools.  Bionano data are available through adoption of Saphyr or through services offerings available around the world. For more information, visit www.bionanogenomics.com.

Contacts

Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionanogenomics.com

Investor Relations Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
+1 (617) 430-7577
arr@lifesciadvisors.com

Media Contact:
Kirsten Thomas
The Ruth Group
+1 (508) 280-6592
kthomas@theruthgroup.com

FAQ

When is Bionano Genomics' conference call to discuss financial results?

Bionano Genomics' conference call is scheduled for June 18, 2020, at 4:30 p.m. Eastern Time.

What will Bionano Genomics report during the conference call?

During the conference call, Bionano Genomics will report its financial results for the first quarter ended March 31, 2020, and provide a business update.

What is the purpose of the Saphyr® platform developed by Bionano Genomics?

The Saphyr® platform is designed for ultra-sensitive and ultra-specific structural variation detection in genome analysis.